Congratulations - Omedetō

By NZ Gastro Office | Posted: Tuesday April 5, 2022

The Society congratulates Dr James Fulforth for being selected to present at the 4th Asian Session in 2023

Dr Fulforth has been selected out of nominees from member Societies of the Asian Pacific Association of Gastroenterology to speak at 4th Asian Session during the 109th General Meeting of the Japanese Society of Gastroenterology (JSGE). 

Dr Fulforth will be presenting Nagasaki, Japan in April 2023 on Therapies for inflammatory bowel diseases and his research on this topic including:  

  • N Plevris, J Fulforth, S Siakavellas, et al.. Real-world effectiveness and safety of ustekinumab for the treatment of Crohn’s disease: The Scottish ustekinumab cohort. Journal of Gastroenterology & Hepatology (2020) doi: 10.1111/jgh.15390
  • Nikolas Plevris, James Fulforth, Mathew Lyons , et al.. Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology (2020) doi: 10.1016/j.cgh.2020.08.022
  • W. Jenkinson, N Plevris, M Lyons, R Grant, J Fulforth, K Kirkwood, ID Arnott, D Wilson, AJM Watson, GR Jones, CW Lees. Analysis of UC colectomy rates in pre- and post-biologic era in Lothian, Scotland. Colorectal Disease (2020) doi: 10.1111/codi.15491